Thursday, February 1, 2018

UPDATE 1-S.Korea's Celltrion shares drop after US FDA warning letter

* Celltrion develops cut-price copies of blockbuster drugs (Adds analyst comment, background, share history)
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)